MedicaidCoverageHigh impact
Skin and Tissue Substitutes - MEDICAID - INDIANA (New)
Humana·IN · Wound Care, Podiatry, Dermatology +3 more·Medicaid
Effective date
May 20, 2026
We identified it
Aug 4, 2026
Summary
Humana Indiana Medicaid has established a new coverage policy for skin and tissue substitutes (effective 05/20/2026) that limits coverage to two specific indications: diabetic foot ulcers and chronic venous leg ulcers, both requiring 4+ weeks duration and strict compliance with standard wound care requirements. All other indications are now considered not medically necessary. Billing teams must immediately identify and update claims submission workflows to align with these coverage restrictions and ensure proper prior authorization documentation.
Action Required
IMMEDIATE (Before 05/20/2026): Billing team must update billing system to flag all skin and tissue substitute claims (HCPCS codes A2001-A2035, A4100, C9354, C9358-C9361, C9363-C9364, Q4101-Q4105 and beyond) for Indiana Medicaid members. Create decision logic in billing software to deny or request prior auth for ANY skin and tissue substitute claims NOT coded for diabetic foot ulcers (DFU) or chronic venous leg ulcers (VLU). For claims that DO code to DFU or VLU: (1) Require documentation proving ulcer duration exceeds 4 weeks; (2) Require evidence of standard wound care compliance including offloading/compression, infection treatment, glucose management, and moist wound dressing maintenance; (3) Require ABI testing and vascular assessment documentation; (4) Verify no exposed bone, capsule, or tendon. For members under age 21, request medical necessity review per EPSDT requirements. Alert providers via EMR/encounter forms about strict coverage limitations. Configure system to automatically deny claims for other indications (breast reconstruction, burns, plantar fasciitis, surgical wounds, ocular defects) with message referencing policy HUM-IN-2643-000. Failure to implement these controls will result in systematic claim denials and revenue loss.